FI50119C - Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi. - Google Patents
Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi.Info
- Publication number
- FI50119C FI50119C FI690659A FI65969A FI50119C FI 50119 C FI50119 C FI 50119C FI 690659 A FI690659 A FI 690659A FI 65969 A FI65969 A FI 65969A FI 50119 C FI50119 C FI 50119C
- Authority
- FI
- Finland
- Prior art keywords
- chlorobenzamido
- sulfamyl
- preparation
- therapeutically effective
- indoline derivatives
- Prior art date
Links
- HICHVRFDQNBHAP-UHFFFAOYSA-N 4-chloro-N-(2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide Chemical class ClC1=C(C=C(C(=O)NN2CCC3=CC=CC=C23)C=C1)S(N)(=O)=O HICHVRFDQNBHAP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB00906/68A GB1203691A (en) | 1968-03-06 | 1968-03-06 | New disubstituted n-amino indoline derivatives and process for preparing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI50119B FI50119B (en:Method) | 1975-09-01 |
| FI50119C true FI50119C (fi) | 1975-12-10 |
Family
ID=9976474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI690659A FI50119C (fi) | 1968-03-06 | 1969-03-05 | Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3565911A (en:Method) |
| BE (1) | BE728658A (en:Method) |
| CH (1) | CH507940A (en:Method) |
| DE (1) | DE1909180A1 (en:Method) |
| DK (1) | DK126193B (en:Method) |
| ES (1) | ES364421A1 (en:Method) |
| FI (1) | FI50119C (en:Method) |
| FR (1) | FR2003311A1 (en:Method) |
| GB (1) | GB1203691A (en:Method) |
| IT (1) | IT8049196A0 (en:Method) |
| NL (1) | NL145226B (en:Method) |
| NO (1) | NO128068B (en:Method) |
| SE (1) | SE334887B (en:Method) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4112111A (en) * | 1975-02-26 | 1978-09-05 | Sandoz Ltd. | Indolinylguanidines |
| IT1113879B (it) * | 1979-03-15 | 1986-01-27 | Farmatis Spa | Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo |
| LU82949A1 (fr) * | 1980-11-20 | 1981-06-04 | Usv Pharma Corp | Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension |
| EP0054892B1 (en) * | 1980-12-22 | 1985-09-18 | SCIENCE UNION ET Cie | Synthesis of indolines |
| JPS57206657A (en) * | 1981-06-16 | 1982-12-18 | Mitsui Toatsu Chem Inc | Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component |
| FR2529785A1 (fr) * | 1982-07-09 | 1984-01-13 | Adir | Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne |
| FR2663325B1 (fr) * | 1990-06-14 | 1992-09-04 | Adir | Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique. |
| FR2663324B1 (fr) * | 1990-06-14 | 1992-09-04 | Adir | Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide. |
| FR2677886B1 (fr) * | 1991-06-18 | 1995-03-31 | Adir | Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale. |
| US5319096A (en) * | 1992-04-03 | 1994-06-07 | Hoechst-Roussel Pharmaceuticals Inc. | (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use |
| IT1288123B1 (it) * | 1996-09-04 | 1998-09-10 | Nicox Sa | Uso di nitroderivati per l'incontinenza urinaria |
| EP1545519B1 (en) | 2002-08-19 | 2011-03-23 | Pfizer Inc. | Combination therapy for hyperproliferative diseases |
| US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| JP2008520578A (ja) * | 2004-11-15 | 2008-06-19 | ニトロメッド インコーポレーティッド | 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法 |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| EP2094643B1 (en) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| FR2924713B1 (fr) * | 2007-12-11 | 2010-01-29 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2011149438A1 (en) | 2010-05-28 | 2011-12-01 | Mahmut Bilgic | Combination of antihypertensive agents |
| CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| ES3007652T3 (en) | 2019-01-18 | 2025-03-20 | Astrazeneca Ab | 6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof |
| TW202314018A (zh) * | 2021-06-21 | 2023-04-01 | 荷蘭商Asm Ip私人控股有限公司 | 用於形成包含氧化銦鎵鋅的層之反應器系統及方法 |
| EP4373474A1 (en) | 2021-07-22 | 2024-05-29 | KRKA, D.D., Novo Mesto | Bilayer tablet comprising telmisartan and indapamide |
| EP4295839A1 (en) | 2022-06-20 | 2023-12-27 | KRKA, d.d., Novo mesto | Combination of valsartan and indapamide |
| EP4374855A1 (en) | 2022-11-22 | 2024-05-29 | KRKA, D.D., Novo Mesto | Pharmaceutical dosage form of candesartan and indapamide |
| EP4559899A1 (en) | 2023-11-21 | 2025-05-28 | KRKA, d.d., Novo mesto | Synthesis of 1-amino-2-methyl-2,3-dihydroindole by nitrosating 2-methyl-2,3-dihydro-1h-indole and then reducing the obtained 1-nitroso-2-methyl-2,3-dihydroindole with thiourea dioxide |
-
1968
- 1968-03-06 GB GB00906/68A patent/GB1203691A/en not_active Expired
-
1969
- 1969-02-14 NO NO00613/69A patent/NO128068B/no unknown
- 1969-02-19 BE BE728658D patent/BE728658A/xx not_active IP Right Cessation
- 1969-02-24 DE DE19691909180 patent/DE1909180A1/de active Pending
- 1969-02-25 US US802208A patent/US3565911A/en not_active Expired - Lifetime
- 1969-02-26 DK DK106769AA patent/DK126193B/da unknown
- 1969-03-03 SE SE02903/69A patent/SE334887B/xx unknown
- 1969-03-05 FR FR6906023A patent/FR2003311A1/fr active Pending
- 1969-03-05 ES ES364421A patent/ES364421A1/es not_active Expired
- 1969-03-05 FI FI690659A patent/FI50119C/fi active
- 1969-03-05 NL NL696903421A patent/NL145226B/xx not_active IP Right Cessation
- 1969-03-05 CH CH334269A patent/CH507940A/fr not_active IP Right Cessation
-
1980
- 1980-07-09 IT IT8049196A patent/IT8049196A0/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK126193B (da) | 1973-06-18 |
| DE1909180A1 (de) | 1970-07-02 |
| BE728658A (en:Method) | 1969-08-19 |
| CH507940A (fr) | 1971-05-31 |
| FI50119B (en:Method) | 1975-09-01 |
| FR2003311A1 (en:Method) | 1969-11-07 |
| US3565911A (en) | 1971-02-23 |
| IT8049196A0 (it) | 1980-07-09 |
| SE334887B (en:Method) | 1971-05-10 |
| NL6903421A (en:Method) | 1969-09-09 |
| GB1203691A (en) | 1970-09-03 |
| NL145226B (nl) | 1975-03-17 |
| NO128068B (en:Method) | 1973-09-24 |
| ES364421A1 (es) | 1971-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI50119C (fi) | Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi. | |
| FI49035C (fi) | Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi. | |
| FI42712C (fi) | Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi | |
| RO59318A (ro) | Procedeu pentru prepararea unor 3-timometil-cefalosporine heterociclice | |
| NO139127C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkylaminer | |
| FI48588C (fi) | Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi. | |
| FI49512C (fi) | Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi. | |
| FI50410C (fi) | Menetelmä tulehdusta estävien substituoitujen aminopyriinien valmistam iseksi | |
| FI45041C (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi. | |
| FI51342C (fi) | Menetelmä uusien, terapeuttisesti vaikuttavien hydroksifenyylialkyylia miinijohdannaisten valmistamiseksi. | |
| FI49504C (fi) | Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi. | |
| FI51179C (fi) | Menetelmä uusien hypoglykeemisesti vaikuttavien 1-(p-asyyliaminoalkyyl i-fenyylisulfonyyli)-2-imino-imidatsolidiinien valmistamiseksi. | |
| SE397971B (sv) | Forfarande for framstellning av halogenmetyl-1,3-polyhalogen-2-propyletrar | |
| FI50972C (fi) | Menetelmä terapeuttisesti arvokkaiden, vasemmalle kiertävien indolijoh dannaisten valmistamiseksi. | |
| FI50420C (fi) | Menetelmä terapeuttisesti aktiivisten 4-pyrimidinyyli-1,4-dihydropyrid iinijohdannaisten valmistamiseksi | |
| DK136982B (da) | Fremgangsmåde til fremstilling af quinolinderivater. | |
| FI51349C (fi) | Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi. | |
| SE398232B (sv) | Forfarande for framstellning av bensodiazepinderivat | |
| FI52577C (fi) | Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi. | |
| FI46157C (fi) | Menetelmä 18-metyyli-5alfa-H-androstaanijohdannaisten valmistamiseksi. | |
| FI44627C (fi) | Menetelmä uusien farmakologisesti tehokkaiden etanoantraseenijohdannai sten valmistamiseksi. | |
| NO140103C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme penicilliner | |
| BG19178A3 (bg) | Метод за получаване на 8-субституирани-5н-пироло-(2,1-с) 1,4 бензодиазепин-5-они | |
| FI52860C (fi) | Menetelmä terapeuttisesti käytettävien indolien valmistamiseksi. | |
| FI45553C (fi) | Menetelmä terapeuttisesti käytettävien 16-tiosubstituoitujen 9beta,10a lfa-pregneenien valmistamiseksi |